New Delhi, April 2 Emcure Pharmaceuticals announced on Thursday a reduction in the price of its weight management drug, Poviztra, a semaglutide injection, by up to 55 per cent to improve patient access.The starting dose of Poviztra (0.25 mg) will now be available for Rs 3,999 per month...
New Delhi, March 2 Emcure Pharmaceuticals announced on Monday that it has signed a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio.Under the agreement, which takes effect on April 1, 2026, Emcure will distribute Roche's established and...
anemia
cellcept
chronic kidney disease
ckd
distribution agreement
emcurepharmaceuticals
immunosuppressant
india
mircera
neorecormon
nephrology
pharmaceutical distribution
roche
therapy
transplant medicine